All News
Anti-CD38-Based Quadruplet Improves Outcomes in Transplant-Ineligible Myeloma
(MedPage Today) -- Daratumumab (Darzalex) plus the standard triplet of bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (D-VRd) significantly improved clinical outcomes versus VRd alo
Read MoreGatos domésticos con gripe aviar podrían ser un riesgo para la salud pública
Un pequeño pero creciente número de gatos domésticos se han enfermado con H5N1, la cepa de gripe aviar protagonista del brote actual en el país, después de comer alimentos crudos o beber leche si
Read MoreBill Would Allow AI to Prescribe Drugs
(MedPage Today) -- Artificial intelligence (AI) could be used to prescribe medications to patients -- if a new bill makes its way through Congress. The proposed legislation, sponsored by Rep.
Read MoreMajor Heart Risks Similar With Two IBD Drugs in Older Adults
(MedPage Today) -- For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major cardiovascular adverse events (MACE) for those taking ustekinumab (
Read MoreWhen Cardiac Warning Signs Go Unrecognized
(MedPage Today) -- In November 2023, what should have been a routine dinner outing with my family turned into a tragedy.
Read MoreResearchers Fearful of Political Sway Over Grants After Trump's DEI Orders
(MedPage Today) -- President Trump's crackdown on diversity, equity, and inclusion (DEI) initiatives in programs receiving federal money has thrown into doubt the future of research Kendra Dahmer, Ph
Read MoreSTAT+: Mass General Brigham announces largest layoff in its history amid ongoing restructuring
Mass General Brigham said Monday it will let go of hundreds of employees in the next two months, the largest layoff in the organization’s history.
Read MoreCertain Diabetes Medications May Ease COPD
(MedPage Today) -- SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of chronic obstructive pulmonary disease (COPD), according to propensity score-matched cohort
Read More22 states sue to block Trump administration cuts to NIH research payments
Attorneys general sued the Trump administration to block a NIH decision that would slash grant payments for research overhead
Read MoreSTAT+: FDA cites Indian ingredients supplier for deleting records
The FDA warning highlights ongoing anxiety over quality control among pharmaceutical manufacturers in India.
Read More